Stock FBLG FIBROBIOLOGICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Company FibroBiologics, Inc.

Equities

FBLG

US31573L1052

Biotechnology & Medical Research

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-06-07 pm EDT 		5-day change 1st Jan Change
9.59 USD -6.98% Intraday chart for FibroBiologics, Inc. -21.26% 0.00%
May. 14 FibroBiologics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Apr. 25 FibroBiologics, Inc. Plans to Collaborate with Charles River Laboratories to Manufacture Fibroblast-Based Spheroids CI

Business Summary

FibroBiologics Inc is a United States-based company. The Company operates as a biopharmaceutical company. It is focused on developing and commercializing fibroblast cell-based therapies for patients suffering from chronic diseases. It also develops biologic cures and treatments for chronic diseases, including degenerative disc disease, multiple sclerosis, wound healing, and cancer, and anti-aging extension of life applications such as thymic involution reversal and splenic involution reversal.

Number of employees: 10

Managers

Managers TitleAgeSince
Peter O'Heeron CEO
 Chief Executive Officer 61 21-04-07
Mark Andersen DFI
 Director of Finance/CFO 53 22-05-31
Hamid Khoja CTO
 Chief Tech/Sci/R&D Officer 55 21-07-31

Members of the board

Members of the board TitleAgeSince
Robert Hoffman BRD
 Director/Board Member 58 21-04-07
Richard C. Cilento BRD
 Director/Board Member 61 21-04-07
Peter O'Heeron CEO
 Chief Executive Officer 61 21-04-07
Matthew Link BRD
 Director/Board Member 49 21-04-07
Stacy Coen BRD
 Director/Board Member 53 21-06-30
Victoria Niklas BRD
 Director/Board Member 64 21-04-07

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 32,719,125 22,794,283 ( 69.67 %) 0 69.67 %

Shareholders

NameEquities%Valuation
Peter O'Heeron
18.49 %
6,048,147 18.49 % 74 M $
Millennium Management LLC
0.6395 %
209,231 0.6395 % 3 M $
Richard C. Cilento
0.2849 %
93,225 0.2849 % 1 M $
HRT Financial LLC
0.1753 %
57,344 0.1753 % 698 450 $
Marshall Wace LLP
0.1590 %
52,025 0.1590 % 633 665 $
Citigroup Global Markets, Inc. (Investment Management)
0.0930 %
30,419 0.0930 % 370 503 $
ExodusPoint Capital Management LP
0.0782 %
25,591 0.0782 % 311 698 $
JPMorgan Securities LLC
0.0692 %
22,634 0.0692 % 275 682 $
NewEdge Advisors LLC
0.0547 %
17,906 0.0547 % 218 095 $
Point72 Difc Ltd.
0.0486 %
15,915 0.0486 % 193 845 $
NameEquities%Valuation
Peter O'Heeron
100.00 %
2,500 100.00 % 30 450 $

Company contact information

FibroBiologics, Inc.

455 East Medical Center Boulevard Suite 300

77598, Houston

+281 651 5150

http://www.fibrobiologics.com
address FibroBiologics, Inc.(FBLG)

Sector

Healthcare
Pharmaceuticals & Medical Research
Biotechnology & Medical Research
Biotechnology & Medical Research
Bio Therapeutic Drugs

Sector Bio Therapeutic Drugs

1st Jan change Capi.
FIBROBIOLOGICS, INC. Stock FibroBiologics, Inc.
0.00% 314M
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
+18.72% 125B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
+14.19% 108B
BIONTECH SE Stock BioNTech SE
-4.93% 24.21B
ARGENX SE Stock argenx SE
+1.22% 22.78B
GENMAB A/S Stock Genmab A/S
-11.14% 17.96B
WUXI APPTEC CO., LTD. Stock WuXi AppTec Co., Ltd.
-41.74% 16.43B
BEIGENE, LTD. Stock BeiGene, Ltd.
-13.31% 16.37B
NEUROCRINE BIOSCIENCES, INC. Stock Neurocrine Biosciences, Inc.
+2.44% 13.58B
SAREPTA THERAPEUTICS, INC. Stock Sarepta Therapeutics, Inc.
+27.89% 11.66B
Bio Therapeutic Drugs
  1. Stock Market
  2. Equities
  3. FBLG Stock
  4. Company FibroBiologics, Inc.